Dr. Reddy’s Laboratories Ltd ADR (RDY) Annual Income Statement (USD)
RDY Quarterly Financials (USD)
Frequently Asked Questions About Dr. Reddy’s Laboratories Ltd ADR (RDY) Stock
Dr. Reddy’s Laboratories Ltd ADR's (RDY) last reported annual revenue was USD 245.88 Billion.
Dr. Reddy’s Laboratories Ltd ADR's (RDY) annual revenue growth rate based on the revenue reported in the past 5 years is : 11.60%
Dr. Reddy’s Laboratories Ltd ADR's(RDY) is profitable as of its last reported annual financials.
The net profit margin for Dr. Reddy’s Laboratories Ltd ADR's(RDY) from its laster reported year is 18.33%
The return on equity (ROE) for Dr. Reddy’s Laboratories Ltd ADR's(RDY) from its last reported annual financials is : 21.77%
The return on assets (ROA) for Dr. Reddy’s Laboratories Ltd ADR's(RDY) from its last reported annual financials is : 11.67%
The return on invested capital (ROIC) for Dr. Reddy’s Laboratories Ltd ADR's(RDY) from its last reported annual financials is : 34.45%
The Debt to Equity ratio for Dr. Reddy’s Laboratories Ltd ADR's(RDY) from its last reported annual financials is : 0.00%
The dividend yield for Dr. Reddy’s Laboratories Ltd ADR's(RDY) from its laster reported year is 0.71%
Dr. Reddy’s Laboratories Ltd ADR's(RDY) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RDY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
